Low stage follicular lymphoma: Biologic and clinical characterization according to nodal or extranodal primary origin

American Journal of Surgical Pathology

Volumn 33, Issue 4, 2009, Pages 591-598

  Weinberg, Olga K ^a   Ma, Lisa ^a   Seo, Katie ^a   Beck, Andrew H ^a   Pai, Reetesh K ^a   Morales, Anjali ^b   Kim, Youn ^b   Sundram, Uma ^a   Tan, Daryl ^c   Horning, Sandra J ^a   Hoppe, Richard T ^d   Natkunam, Yasodha ^a   Arber, Daniel A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Departments of Dermatology   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD CANCER INSTITUTE   (United States)

Author keywords

Breakpoints; Extranodal; Follicular lymphoma; HGAL; LMO2; Low stage; T(14, 18)

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER STAGING; CHROMOSOME 14; CHROMOSOME 18; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; GENE TRANSLOCATION; GENETICS; HUMAN; LYMPH NODE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; SKIN TUMOR; SURVIVAL RATE; UNITED STATES;

CALIFORNIA; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 63849111699     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31818e6489     Document Type: Article

References (32)

1. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy. J Clin Oncol. 2004;22:1454-1459.
2. Armitage JO, Weisenburger DD. New approach to classifying non- Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-2795.
3. Bacon CM, Ye H, Diss TC, et al. Primary follicular lymphoma of the testis and epididymis in adults. Am J Surg Pathol. 2007;31:1050-1058.
4. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579-586.
5. Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract: A study of 25 cases and a literature review. Ann Oncol. 2003;14:623-629.
6. Derringer GA, Thompson LD, Frommelt RA, et al. Malignant lymphoma of the thyroid gland: A clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24:623-639.
7. Dogan A, Bagdi E, Munson P, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000;24:846-852.
8. Ferry JA, Harris NL, Young RH, et al. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol. 1994; 18:376-390.
9. Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007;31:170-184.
10. Goodlad JR, Krajewski AS, Batstone PJ, et al. Primary cutaneous follicular lymphoma: A clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am J Surg Pathol. 2002;26: 733-741.
11. Goodlad JR, MacPherson S, Jackson R, et al. Scotland and Newcastle Lymphoma Group. Extranodal follicular lymphoma: A clinicopathological and genetic analysis of 15 cases arising at noncutaneous extranodal sites. Histopathology. 2004;44:268-276.
12. Goodlad JR, Batstone PJ, Hamilton DA, et al. BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma. Histopathology. 2006;49:229-241.
13. Jaffe ES, Stein H, Vardiman DW, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2001:351.
14. Kempton CL, Kurtin PJ, Inwards DJ, et al. Malignant lymphoma of the bladder: Evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol. 1997;21:1324-1333.
15. Kim BK, Surti U, Pandya A, et al. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas. Am J Surg Pathol. 2005;29:69-82.
16. Kojima M, Nakamura S, Ichimura K, et al. Follicular lymphoma of the salivary gland: A clinicopathological and molecular study of six cases. Int J Surg Pathol. 2001;9:287-293.
17. Kojima M, Shimizu K, Nishikawa M, et al. Primary salivary gland lymphoma among Japanese: A clinicopathological study of 30 cases. Leuk Lymphoma. 2007;48:1793-1798.
18. Kosari F, Daneshbod Y, Parwaresch R, et al. Lymphomas of the female genital tract: A study of 186 cases and review of the literature. Am J Surg Pathol. 2005;29:1512-1520.
19. Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol. 1996;14:1282-1290.
20. Naresh KN. Nodal marginal zone B-cell lymphoma with prominent follicular colonization-difficulties in diagnosis: A study of 15 cases. Histopathology. 2008;52:331-339.
21. Natkunam Y, Soslow R, Matolcsy A, et al. Immunophenotypic and genotypic characterization of progression in follicular lymphomas. Appl Immunohistochem Mol Morphol. 2004;12:97-104.
22. Natkunam Y, Lossos IS, Taidi B, et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood. 2005;105: 3979-3986.
23. Natkunam Y, Zhao S, Mason DY, et al. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood. 2007;109:1636-1642.
24. Plancarte F, López-Guillermo A, Arenillas L, et al. Follicular lymphoma in early stages: High risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Eur J Haematol. 2006;76:58-63.
25. Shia J, Teruya-Feldstein J, Pan D, et al. Primary follicular lymphoma of the gastrointestinal tract: A clinical and pathologic study of 26 cases. Am J Surg Pathol. 2002;26:216-224.
26. Streubel B, Scheucher B, Valencak J, et al. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol. 2006;30:529-536.
27. Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258-1265.
28. Tsang RW, Gospodarowicz MK. Low Grade non-Hodgkin lymphomas. Semin Radiat Oncol. 2007;17:198-205.
29. Weinberg OK, Ai WZ, Mariappan MR, et al. "Minor" BCL2 breakpoints in follicular lymphoma: Frequency and correlation with grade and disease presentation in 236 cases. J Mol Diagn. 2007;9: 530-537.
30. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
31. Yang B, Tubbs RR, Finn W, et al. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol. 2000;24: 694-702.
32. Yoshino T, Miyake K, Ichimura K, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol. 2000;24: 688-693.